AMN HEALTHCARE SERVICES INC (AMN) Stock Fundamental Analysis
NYSE:AMN - New York Stock Exchange, Inc. - US0017441017 - Common Stock - Currency: USD
Overall AMN gets a fundamental rating of 4 out of 10. We evaluated AMN against 108 industry peers in the Health Care Providers & Services industry. AMN has only an average score on both its financial health and profitability. A decent growth rate in combination with a cheap valuation! Better keep an eye on AMN.
1. Profitability
1.1 Basic Checks
In the past year AMN was profitable.
In the past year AMN had a positive cash flow from operations.
AMN had positive earnings in 4 of the past 5 years.
In the past 5 years AMN always reported a positive cash flow from operatings.
1.2 Ratios
Looking at the Return On Assets, with a value of -6.08%, AMN is doing worse than 66.36% of the companies in the same industry.
With a Return On Equity value of -20.80%, AMN is not doing good in the industry: 64.49% of the companies in the same industry are doing better.
AMN has a Return On Invested Capital of 4.75%. This is comparable to the rest of the industry: AMN outperforms 57.94% of its industry peers.
AMN had an Average Return On Invested Capital over the past 3 years of 13.14%. This is significantly above the industry average of 8.12%.
The last Return On Invested Capital (4.75%) for AMN is well below the 3 year average (13.14%), which needs to be investigated, but indicates that AMN had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -6.08% | ||
| ROE | -20.8% | ||
| ROIC | 4.75% |
ROA(3y)5.5%
ROA(5y)5.99%
ROE(3y)15.7%
ROE(5y)16.78%
ROIC(3y)13.14%
ROIC(5y)12.94%
1.3 Margins
AMN has a Operating Margin of 4.01%. This is comparable to the rest of the industry: AMN outperforms 57.01% of its industry peers.
AMN's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 30.81%, AMN perfoms like the industry average, outperforming 55.14% of the companies in the same industry.
AMN's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.01% | ||
| PM (TTM) | N/A | ||
| GM | 30.81% |
OM growth 3Y-31.99%
OM growth 5Y-12.8%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.13%
GM growth 5Y-1.63%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), AMN is creating some value.
Compared to 1 year ago, AMN has more shares outstanding
The number of shares outstanding for AMN has been reduced compared to 5 years ago.
The debt/assets ratio for AMN has been reduced compared to a year ago.
2.2 Solvency
AMN has an Altman-Z score of 2.52. This is not the best score and indicates that AMN is in the grey zone with still only limited risk for bankruptcy at the moment.
AMN's Altman-Z score of 2.52 is in line compared to the rest of the industry. AMN outperforms 58.88% of its industry peers.
AMN has a debt to FCF ratio of 4.41. This is a neutral value as AMN would need 4.41 years to pay back of all of its debts.
AMN has a Debt to FCF ratio of 4.41. This is in the better half of the industry: AMN outperforms 73.83% of its industry peers.
AMN has a Debt/Equity ratio of 1.49. This is a high value indicating a heavy dependency on external financing.
AMN has a Debt to Equity ratio of 1.49. This is in the lower half of the industry: AMN underperforms 71.96% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.49 | ||
| Debt/FCF | 4.41 | ||
| Altman-Z | 2.52 |
ROIC/WACC0.62
WACC7.62%
2.3 Liquidity
AMN has a Current Ratio of 1.09. This is a normal value and indicates that AMN is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of AMN (1.09) is worse than 73.83% of its industry peers.
A Quick Ratio of 1.09 indicates that AMN should not have too much problems paying its short term obligations.
AMN has a worse Quick ratio (1.09) than 65.42% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.09 | ||
| Quick Ratio | 1.09 |
3. Growth
3.1 Past
AMN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -59.44%.
The Earnings Per Share has been growing slightly by 0.80% on average over the past years.
AMN shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -21.26%.
AMN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.07% yearly.
EPS 1Y (TTM)-59.44%
EPS 3Y-25.55%
EPS 5Y0.8%
EPS Q2Q%-43.18%
Revenue 1Y (TTM)-21.26%
Revenue growth 3Y-9.19%
Revenue growth 5Y6.07%
Sales Q2Q%-10.21%
3.2 Future
The Earnings Per Share is expected to grow by 22.82% on average over the next years. This is a very strong growth
Based on estimates for the next years, AMN will show a small growth in Revenue. The Revenue will grow by 4.40% on average per year.
EPS Next Y-54.47%
EPS Next 2Y-18.52%
EPS Next 3Y26.6%
EPS Next 5Y22.82%
Revenue Next Year-8.88%
Revenue Next 2Y-2.64%
Revenue Next 3Y3.41%
Revenue Next 5Y4.4%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
AMN is valuated cheaply with a Price/Earnings ratio of 7.42.
Based on the Price/Earnings ratio, AMN is valued cheaper than 96.26% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 29.75. AMN is valued rather cheaply when compared to this.
With a Price/Forward Earnings ratio of 16.30, AMN is valued correctly.
Compared to the rest of the industry, the Price/Forward Earnings ratio of AMN indicates a somewhat cheap valuation: AMN is cheaper than 71.03% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.44, AMN is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.42 | ||
| Fwd PE | 16.3 |
4.2 Price Multiples
88.78% of the companies in the same industry are more expensive than AMN, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, AMN is valued cheaper than 99.07% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 3.91 | ||
| EV/EBITDA | 6.84 |
4.3 Compensation for Growth
A more expensive valuation may be justified as AMN's earnings are expected to grow with 26.60% in the coming years.
PEG (NY)N/A
PEG (5Y)9.23
EPS Next 2Y-18.52%
EPS Next 3Y26.6%
5. Dividend
5.1 Amount
AMN does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
24.57
-0.75 (-2.96%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners108.48%
Inst Owner Change-7.98%
Ins Owners0.39%
Ins Owner Change5.16%
Market Cap935.38M
Analysts69.23
Price Target37.74 (53.6%)
Short Float %10.01%
Short Ratio4.85
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)28.79%
Min EPS beat(2)5.34%
Max EPS beat(2)52.24%
EPS beat(4)4
Avg EPS beat(4)21.5%
Min EPS beat(4)0.39%
Max EPS beat(4)52.24%
EPS beat(8)8
Avg EPS beat(8)15.49%
EPS beat(12)12
Avg EPS beat(12)13.71%
EPS beat(16)16
Avg EPS beat(16)15.17%
Revenue beat(2)2
Avg Revenue beat(2)3.07%
Min Revenue beat(2)1.38%
Max Revenue beat(2)4.75%
Revenue beat(4)2
Avg Revenue beat(4)1.18%
Min Revenue beat(4)-0.96%
Max Revenue beat(4)4.75%
Revenue beat(8)4
Avg Revenue beat(8)0.55%
Revenue beat(12)8
Avg Revenue beat(12)1.43%
Revenue beat(16)12
Avg Revenue beat(16)2.56%
PT rev (1m)0%
PT rev (3m)-10.38%
EPS NQ rev (1m)-29.1%
EPS NQ rev (3m)-37.46%
EPS NY rev (1m)0%
EPS NY rev (3m)-13.13%
Revenue NQ rev (1m)1.87%
Revenue NQ rev (3m)1.87%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.42 | ||
| Fwd PE | 16.3 | ||
| P/S | 0.31 | ||
| P/FCF | 3.91 | ||
| P/OCF | 2.92 | ||
| P/B | 1.32 | ||
| P/tB | N/A | ||
| EV/EBITDA | 6.84 |
EPS(TTM)3.31
EY13.47%
EPS(NY)1.51
Fwd EY6.13%
FCF(TTM)6.29
FCFY25.61%
OCF(TTM)8.42
OCFY34.26%
SpS78.38
BVpS18.56
TBVpS-15.03
PEG (NY)N/A
PEG (5Y)9.23
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -6.08% | ||
| ROE | -20.8% | ||
| ROCE | 6.41% | ||
| ROIC | 4.75% | ||
| ROICexc | 4.77% | ||
| ROICexgc | 15.29% | ||
| OM | 4.01% | ||
| PM (TTM) | N/A | ||
| GM | 30.81% | ||
| FCFM | 8.03% |
ROA(3y)5.5%
ROA(5y)5.99%
ROE(3y)15.7%
ROE(5y)16.78%
ROIC(3y)13.14%
ROIC(5y)12.94%
ROICexc(3y)13.46%
ROICexc(5y)13.47%
ROICexgc(3y)46.83%
ROICexgc(5y)47.63%
ROCE(3y)17.73%
ROCE(5y)17.46%
ROICexcg growth 3Y-38.44%
ROICexcg growth 5Y-11.09%
ROICexc growth 3Y-36.92%
ROICexc growth 5Y-11.74%
OM growth 3Y-31.99%
OM growth 5Y-12.8%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.13%
GM growth 5Y-1.63%
F-Score3
Asset Turnover1.24
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.49 | ||
| Debt/FCF | 4.41 | ||
| Debt/EBITDA | 3.6 | ||
| Cap/Depr | 46.55% | ||
| Cap/Sales | 2.71% | ||
| Interest Coverage | 1.96 | ||
| Cash Conversion | 109.15% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.09 | ||
| Quick Ratio | 1.09 | ||
| Altman-Z | 2.52 |
F-Score3
WACC7.62%
ROIC/WACC0.62
Cap/Depr(3y)57.01%
Cap/Depr(5y)52.87%
Cap/Sales(3y)2.35%
Cap/Sales(5y)2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-59.44%
EPS 3Y-25.55%
EPS 5Y0.8%
EPS Q2Q%-43.18%
EPS Next Y-54.47%
EPS Next 2Y-18.52%
EPS Next 3Y26.6%
EPS Next 5Y22.82%
Revenue 1Y (TTM)-21.26%
Revenue growth 3Y-9.19%
Revenue growth 5Y6.07%
Sales Q2Q%-10.21%
Revenue Next Year-8.88%
Revenue Next 2Y-2.64%
Revenue Next 3Y3.41%
Revenue Next 5Y4.4%
EBIT growth 1Y-64.61%
EBIT growth 3Y-38.24%
EBIT growth 5Y-7.5%
EBIT Next Year104.39%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-10.21%
FCF growth 3Y-1.64%
FCF growth 5Y4.92%
OCF growth 1Y-13.9%
OCF growth 3Y1.61%
OCF growth 5Y7.34%